Liquidia (LQDA) Cash from Financing Activities (2020 - 2026)

Liquidia (LQDA) recorded quarterly Cash from Financing Activities of -$18.1 million in Q1 2026, down 157.11% quarter-over-quarter from -$7.0 million in Q4 2025, and down 174.33% on a YoY basis from $24.3 million in Q1 2025.

Liquidia (LQDA) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Liquidia's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at -$18.1 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 174.33% year-over-year to -$18.1 million; the TTM figure through Mar 2026 stood at $17.4 million (down 85.43% YoY), while the FY2025 annual figure was $59.7 million, down 69.32% from the prior year.
  • Cash from Financing Activities was -$18.1 million for Q1 2026 at Liquidia, down from -$7.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $99.7 million in Q1 2024 to a low of -$18.1 million in Q1 2026.
  • Historically, Cash from Financing Activities has averaged $20.3 million across 5 years, with a median of $10.0 million in 2023.
  • The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities soared 41377.19% in 2023, then tumbled 205.84% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $57000.0 in 2022, then jumped by 41377.19% to $23.6 million in 2023, then slumped by 109.71% to -$2.3 million in 2024, then sank by 205.84% to -$7.0 million in 2025, then sank by 157.11% to -$18.1 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$18.1 million (Q1 2026), -$7.0 million (Q4 2025), and -$5.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 1.47 Bn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn -11.62 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -77.88 Mn
10 Liquidia 5.74 Bn 5.52 Bn 121.79 Mn -18.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -18.05 Mn
Mar 31, 2026 -18.05 Mn
Dec 31, 2025 -7.02 Mn
Dec 31, 2025 -7.02 Mn
Sep 30, 2025 -5.25 Mn
Sep 30, 2025 -5.25 Mn
Jun 30, 2025 47.71 Mn
Jun 30, 2025 47.71 Mn
Mar 31, 2025 24.29 Mn
Mar 31, 2025 24.29 Mn
Dec 31, 2024 -2.30 Mn
Dec 31, 2024 -2.30 Mn
Sep 30, 2024 98.10 Mn
Sep 30, 2024 98.10 Mn
Jun 30, 2024 -814,000.00
Jun 30, 2024 -814,000.00
Mar 31, 2024 99.67 Mn
Mar 31, 2024 99.67 Mn
Dec 31, 2023 23.64 Mn
Dec 31, 2023 23.64 Mn